STUDY DESIGN: Retrospective cohort study. OBJECTIVE: This study aimed to identify the rates and causes of unplanned hospital readmission at 30 days and 1 year after surgical treatment of primary and metastatic spinal tumors. SUMMARY OF BACKGROUND DATA: Primary spine tumors and non-spine tumors metastatic to the spine can represent complex problems for surgical treatment, but surgical intervention can provide significant patients with significant improvements in quality of life. However, recent emphasis on decreasing the cost of health care has led to a focus on quality measures such as hospital readmission rates. METHODS: At a large referral spine center between 2005 and 2011, 197 patients with primary (n = 33) or metastatic (n = 164) tumors of the spine were enrolled. Hospital readmissions within 1 year were reviewed. Kaplan-Meier analysis was performed to estimate unplanned hospital readmission rates, and risk factors were evaluated using a Cox proportional hazards model. RESULTS: Unplanned hospital readmission rates were 6.1% and 16.8% at 30 days for primary and metastatic tumors (P = 0.126), respectively, and 27.5% and 37.8% at 1 year (P = 0.262). Metastatic tumors with aggressive biology (i.e., lung, osteosarcoma, stomach, bladder, esophagus, pancreas) caused higher rates of readmission than other types of metastatic tumors. One-third of readmissions were due to recurrent disease, whereas 23.3% were due to surgical complications and 43.3% due to medical complications. Numerous medical comorbidities increased the risk of unplanned hospital readmission. CONCLUSION: Unplanned hospital readmissions after surgical intervention for spine tumors are common, and patients with aggressive metastatic tumors are at increased risk. In addition, comorbid medical problems are important risk factors that increase the chance that a patient will require hospital readmission within 1 year. LEVEL OF EVIDENCE: 3.
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: This study aimed to identify the rates and causes of unplanned hospital readmission at 30 days and 1 year after surgical treatment of primary and metastatic spinal tumors. SUMMARY OF BACKGROUND DATA: Primary spine tumors and non-spine tumors metastatic to the spine can represent complex problems for surgical treatment, but surgical intervention can provide significant patients with significant improvements in quality of life. However, recent emphasis on decreasing the cost of health care has led to a focus on quality measures such as hospital readmission rates. METHODS: At a large referral spine center between 2005 and 2011, 197 patients with primary (n = 33) or metastatic (n = 164) tumors of the spine were enrolled. Hospital readmissions within 1 year were reviewed. Kaplan-Meier analysis was performed to estimate unplanned hospital readmission rates, and risk factors were evaluated using a Cox proportional hazards model. RESULTS: Unplanned hospital readmission rates were 6.1% and 16.8% at 30 days for primary and metastatic tumors (P = 0.126), respectively, and 27.5% and 37.8% at 1 year (P = 0.262). Metastatic tumors with aggressive biology (i.e., lung, osteosarcoma, stomach, bladder, esophagus, pancreas) caused higher rates of readmission than other types of metastatic tumors. One-third of readmissions were due to recurrent disease, whereas 23.3% were due to surgical complications and 43.3% due to medical complications. Numerous medical comorbidities increased the risk of unplanned hospital readmission. CONCLUSION: Unplanned hospital readmissions after surgical intervention for spine tumors are common, and patients with aggressive metastatic tumors are at increased risk. In addition, comorbid medical problems are important risk factors that increase the chance that a patient will require hospital readmission within 1 year. LEVEL OF EVIDENCE: 3.
Authors: Javier Valero-Elizondo; Yuhree Kim; Jason D Prescott; Georgios A Margonis; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2015-08-19 Impact factor: 3.452
Authors: Aladine A Elsamadicy; Owoicho Adogwa; David T Lubkin; Amanda R Sergesketter; Sohrab Vatsia; Eric W Sankey; Joseph Cheng; Carlos A Bagley; Isaac O Karikari Journal: J Spine Surg Date: 2018-06
Authors: Daniel R Evans; Alexander L Lazarides; Mark M Cullen; Jason A Somarelli; Dan G Blazer; Julia D Visguass; Brian E Brigman; William C Eward Journal: Ann Surg Oncol Date: 2021-09-27 Impact factor: 5.344
Authors: Awais K Hussain; Zoe B Cheung; Khushdeep S Vig; Kevin Phan; Mauricio C Lima; Jun S Kim; John Di Capua; Deepak A Kaji; Varun Arvind; Samuel K Cho Journal: Global Spine J Date: 2018-08-26
Authors: Syed Faraz Kazim; Alis J Dicpinigaitis; Christian A Bowers; Smit Shah; William T Couldwell; Rachel Thommen; Daniel J Alvarez-Crespo; Matthew Conlon; Omar H Tarawneh; John Vellek; Kyrill L Cole; Jose F Dominguez; Rohini N Mckee; Christian B Ricks; Peter C Shin; Chad D Cole; Meic H Schmidt Journal: Neurospine Date: 2022-02-02
Authors: Kabir A Torres; Elliot Konrade; Jacob White; Mauro Costa M Tavares Junior; Joshua T Bunch; Douglas Burton; R Sean Jackson; Jacob Birlingmair; Brandon B Carlson Journal: BMC Musculoskelet Disord Date: 2022-08-26 Impact factor: 2.562
Authors: Aladine A Elsamadicy; Andrew B Koo; Wyatt B David; Cheryl K Zogg; Adam J Kundishora; Christopher S Hong; Gregory A Kuzmik; Ramana Gorrepati; Pedro O Coutinho; Luis Kolb; Maxwell Laurans; Khalid Abbed Journal: Spine (Phila Pa 1976) Date: 2021-06-15 Impact factor: 3.241
Authors: Kivanc Atesok; Efstathios Papavassiliou; Michael J Heffernan; Danny Tunmire; Irina Sitnikov; Nobuhiro Tanaka; Sakthivel Rajaram; Jason Pittman; Ziya L Gokaslan; Alexander Vaccaro; Steven Theiss Journal: Global Spine J Date: 2019-01-03